Gefitinib With or Without Tamoxifen in Treating Patients With Tamoxifen-Resistant Metastatic Breast Cancer

NCT00080743 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

2

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: gefitinib
DRUG: tamoxifen citrate
DRUG: Placebo

Sponsor

Dartmouth-Hitchcock Medical Center

Collaborators

[object Object]
[object Object]